ADVFN ADVFN

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Caratteristiche principali

Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Sernova Biotherapeutics Inc

Sernova Biotherapeutics Inc (PSH0)

0,082
-0,0002
( -0,24% )
Aggiornato: 17:02:10

Sernova Biotherapeutics Inc (PSH0) Operazioni degli insider

-
Filtra per:
Data Nome del titolare Azioni transazionate Intervallo di valore ($) Tipo di transazione Intervallo di prezzo ($) Azioni a fine dichiarazione % di variazione
2026-05-22Ms. Tanya N. LewisIndependent Director & Observer426,48k0,00Derivative Acquisition Under Employee Benefit Plan-1,56M37,63%
2026-05-22Mr. David PatersonIndependent Director454,23k0,00Derivative Acquisition Under Employee Benefit Plan-1,73M35,53%
2026-05-22Dr. Stephen SanghaIndependent Director260,00k0,00Derivative Acquisition Under Employee Benefit Plan-2,54M11,40%
2026-05-22Dr. Bernd MuehlenwegIndependent Director433,42k0,00Derivative Acquisition Under Employee Benefit Plan-1,74M33,30%
2026-05-22Mr. John L. BrooksIndependent Chairman588,91k0,00Derivative Acquisition Under Employee Benefit Plan-1,73M51,45%
2026-04-16Dr. Stephen SanghaIndependent Director26,67M2,92MAcquisto0,1149,70M115,76%
2026-04-14Dr. Stephen SanghaIndependent Director10,00M1,09MAcquisto0,1123,04M76,70%
2026-04-14Mr. Jonathan M. N. RigbyPresident, CEO & Director229,88k31,74kAcquisto0,14229,88k-
2026-04-14Mr. James T. ParsonsCFO229,88k31,74kAcquisto0,14614,61k59,75%
2026-03-03Mr. James T. ParsonsCFO-100,00k0,00Other Derivative Disposition-0,00-100,00%
2026-03-03Dr. Stephen SanghaIndependent Director-880,00k0,00Other Derivative Disposition-16,00M-5,21%
2026-02-24Mr. John L. BrooksIndependent Chairman1,14M0,00Derivative Acquisition Under Employee Benefit Plan-1,14M-
2026-02-24Mr. James T. ParsonsCFO2,25M0,00Derivative Acquisition Under Employee Benefit Plan-7,32M44,38%
2026-02-24Mr. Jonathan M. N. RigbyPresident, CEO & Director3,80M0,00Derivative Acquisition Under Employee Benefit Plan-19,98M23,48%
2026-02-24Dr. Bernd MuehlenwegIndependent Director337,47k0,00Derivative Acquisition Under Employee Benefit Plan-1,30M35,00%
2026-02-24Dr. Pericles CaliasChief Development Officer and Head of R&D600,00k0,00Derivative Acquisition Under Employee Benefit Plan-1,60M60,00%
2026-02-24Dr. Stephen SanghaIndependent Director880,00k0,00Derivative Acquisition Under Employee Benefit Plan-2,28M62,85%
2026-02-24Mr. David PatersonIndependent Director377,97k0,00Derivative Acquisition Under Employee Benefit Plan-1,28M41,97%
2026-02-24Ms. Tanya N. LewisIndependent Director & Observer323,97k0,00Derivative Acquisition Under Employee Benefit Plan-1,13M40,03%
2026-02-24Dr. Stephen SanghaIndependent Director269,98k0,00Derivative Acquisition Under Employee Benefit Plan-1,40M23,89%
2025-08-14Ms. Tanya N. LewisIndependent Director & Observer389,32k0,00Derivative Acquisition Under Employee Benefit Plan-809,32k92,70%
2025-08-14Dr. Bernd MuehlenwegIndependent Director404,19k0,00Derivative Acquisition Under Employee Benefit Plan-964,19k72,18%
2025-08-14Dr. Stephen SanghaIndependent Director420,26k0,00Derivative Acquisition Under Employee Benefit Plan-1,13M59,19%
2025-08-14Mr. David PatersonIndependent Director410,53k0,00Derivative Acquisition Under Employee Benefit Plan-900,53k83,78%
2025-08-01Mr. Jeffrey A. BachaInsider-5,00k724,68Vendita0,14325,00k-1,52%